ABSTRACT
COVID-19 is a multisystemic disease, and hence its potential manifestations on nuclear medicine imaging can extend beyond the lung. Therefore, it is important for the nuclear medicine physician to recognize these manifestations in the clinic. While FDG-PET/CT is not indicated routinely in COVID-19 evaluation, its unique capability to provide a functional and anatomical assessment of the entire body means that it can be a powerful tool to monitor acute, subacute, and long-term effects of COVID-19. Single-photon scintigraphy is routinely used to assess conditions such as pulmonary embolism, cardiac ischemia, and thyroiditis, and COVID-19 may present in these studies. The most common nuclear imaging finding of COVID-19 vaccination to date is hypermetabolic axillary lymphadenopathy. This may pose important diagnostic and management dilemmas in oncologic patients, particularly those with malignancies where the axilla constitutes a lymphatic drainage area. This article aims to summarize the relevant literature published since the beginning of the pandemic on the intersection between COVID-19 and nuclear medicine.
Subject(s)
COVID-19 , Nuclear Medicine , Humans , Positron Emission Tomography Computed Tomography , COVID-19 Vaccines , Fluorodeoxyglucose F18 , Radionuclide Imaging , Positron-Emission Tomography , ToesABSTRACT
RATIONALE AND OBJECTIVES: To understand the current state of radiology residents' exposure to nuclear medicine and molecular imaging (NM/MI), determine key factors that may attract more trainees into the field, and identify differentiating aspects between those specializing in NM/MI and those who are not. MATERIALS AND METHODS: An anonymous web-based survey was sent to contacts at all diagnostic radiology residency programs in the United States for dissemination to their residents, collecting information about trainees' NM/MI exposure during residency and factors that may attract them to NM/MI. RESULTS: A total of 198 trainees responded to the survey, 34 of whom plan on pursuing a career in NM/MI. Most trainees reported early exposure to NM/MI during residency; most (97.4%) reported ample exposure to general NM/MI and oncologic studies. Less than 3% of trainees reported adequate exposure to therapies, neurological applications, molecular imaging/research advances, and physics. Respondents reported a need for better quality education (38.9%) and exposure to mentors (28.8%) as ways to attract trainees to NM/MI. Routinely encountered clinical pathology was the most interesting for those specializing in NM/MI (29.4%), whereas lifestyle was the most attractive aspect of NM/MI for those not pursuing a career in the field (27.4%). NM/MI-associated research was the least attractive for those specializing in NM/MI (35.3%), while job market concerns was the least attractive aspect for those not specializing in NM/MI (37.2%). Trainees planning to specialize in NM/MI reported higher satisfaction with their orientation to NM/MI during their first clinical rotation compared to those who do not plan to specialize in the field (3.03/5.00 and 2.67/5.00, respectively, p = 0.04). CONCLUSION: This survey highlights several factors that training programs and national societies can target to improve interest in NM/MI among radiology residents. We found that optimized education initiatives, including improved orientation to the field, increased mentoring, and career opportunities are essential levers for recruiting radiology trainees into the NM/MI workforce.
Subject(s)
Internship and Residency , Nuclear Medicine , Humans , United States , Radiography , Surveys and Questionnaires , Radionuclide Imaging , Career ChoiceABSTRACT
BACKGROUND/AIMS: Gastric emptying scintigraphy is commonly performed to assess for dysmotility. A standardized meal with associated threshold criteria was established in 2000 to enable robust interpretation. However, no guidance is available to interpret results when patients do not ingest the entire meal. The purpose of this study is to determine the continued appropriateness of the threshold criteria in contemporary clinical practice and its relevance for partially ingested meals. METHODS: This retrospective study analyzed patients (n = 1365 total) who underwent solid-phase gastric emptying scintigraphy at an academic medical center. Patients were stratified based on their completion of the standard meal. Patients were further stratified into normal and delayed gastric emptying cohorts based on the current criteria. Percent gastric retention values at 1, 2, 3, and 4 h were compared. RESULTS: Median (95% upper reference) normal gastric retention values for the complete standard meal were 64% (87%) at 1 h, 25% (60%) at 2 h, 13% (54%) at 3 h and 4% (9%) at 4 h. Consumption of at least 50% of the standard meal yielded similar retention; 53% (86%) at 1 h, 19% (58%) at 2 h, 6% (29%) at 3 h and 3% (10%) at 4 h. There was no significant age- or gender-specific differences using the current criteria, and no differences were observed based on diabetic status. Retention values matched well with the current criteria and validated with data-driven clustering. CONCLUSION: Adult normative standards for gastric emptying scintigraphy are appropriate for differentiating normal and delayed populations and can be applied to partial meals with at least 50% completion.
Subject(s)
Gastric Emptying , Meals , Humans , Adult , Retrospective Studies , Radionuclide Imaging , EatingABSTRACT
Lymphoma is the most common hematologic malignancy comprising a diverse group of neoplasms arising from multiple blood cell lineages. Any structure of the thorax may be involved at any stage of disease. Imaging has a central role in the initial staging, response assessment, and surveillance of lymphoma, and updated standardized assessment criteria are available to assist with imaging interpretation and reporting. Radiologists should be aware of the modern approaches to lymphoma treatment, the role of imaging in posttherapeutic surveillance, and manifestations of therapy-related complications.
Subject(s)
Lymphoma , Diagnostic Imaging , Disease Progression , Humans , Lymphoma/diagnostic imaging , Lymphoma/pathology , Lymphoma/therapy , Neoplasm Staging , ThoraxSubject(s)
Chromosome Aberrations , Drug Resistant Epilepsy , Occipital Lobe , Tomography, Emission-Computed, Single-Photon/methods , Adolescent , Chromosomes, Human, Pair 19 , Drug Resistant Epilepsy/diagnostic imaging , Drug Resistant Epilepsy/pathology , Drug Resistant Epilepsy/physiopathology , Electroencephalography , Humans , Male , Neuroimaging/methods , Neurosurgical Procedures , Occipital Lobe/diagnostic imaging , Occipital Lobe/pathology , Preoperative CareABSTRACT
Paraneoplastic syndromes are a rare clinical presentation of tumor thought to affect 0.01% of patients with cancer. Paraneoplastic syndromes present a diagnostic challenge as a wide variety of signs and symptoms may appear. This study examines the use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) as a diagnostic imaging tool for detecting tumor in suspected paraneoplastic syndrome cases. This single-center retrospective study included patients with suspected paraneoplastic syndrome who underwent whole-body 18F-FDG PET/CT scan between December 2005 and December 2016. Associated clinical data were gathered via electronic chart review. Patient records were reviewed for age, sex, clinical signs and symptoms, ancillary diagnostic procedures, date of diagnosis, and follow-up time. Ninety-nine patients met inclusion criteria for this study. Mean follow-up period was 1.8 years. Cancer prevalence was 12.1%. The 18F-FDG PET/CT results are as follows: 10 true positives, 5 false positives, 82 true negatives, and 2 false negatives. The diagnostic values are as follows: sensitivity 83.3%, specificity 94.3%, positive predictive value 66.7%, and negative predictive value (NPV) 97.6%. The high NPV in our study supports the effectiveness of 18F-FDG PET/CT to rule out tumor in suspected paraneoplastic syndrome. Future research aims to analyze which patients with suspected paraneoplastic syndrome would benefit most from 18F-FDG PET/CT.
ABSTRACT
OBJECTIVE. We reviewed a retrospective series of 126 18F-fluciclovine PET/CT studies of patients with biochemically recurrent prostate cancer at low (< 1 ng/mL) and very low (< 0.3 ng/mL) prostate-specific antigen (PSA) levels. CONCLUSION. The rate of PET/CT positivity was 33% (15/46) in patients with low PSA levels and 0% (0/17) in patients with very low PSA levels. Our results suggest that 18F-fluciclovine PET/CT can be helpful for localizing recurrence in patients with PSA levels between 0.3 and 1 ng/mL and that 18F-fluciclovine PET/CT is not recommended in patients with PSA levels less than 0.3 ng/mL.
Subject(s)
Carboxylic Acids , Cyclobutanes , Neoplasm Recurrence, Local/diagnostic imaging , Positron Emission Tomography Computed Tomography , Prostatic Neoplasms/diagnostic imaging , Radiopharmaceuticals , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/pathology , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Neoplasms/blood , Prostatic Neoplasms/surgery , Reproducibility of Results , Retrospective StudiesABSTRACT
Fluorodeoxyglucose positron emission tomography computed tomography (FDG-PET/CT) provides a comprehensive whole body evaluation in patients with endometrial and vulvar cancer. Here, we discuss the role of FDG-PET/CT in defining the disease extent in patients presenting with these cancers. Detection of lymph node and distant metastases has implications for staging, treatment planning, and patient prognosis. Procedures for image acquisition and interpretation for optimum accuracy and essential elements that should be included in the PET-CT report are described. Common imaging pitfalls are presented and illustrated with examples.
Subject(s)
Endometrial Neoplasms/diagnostic imaging , Fluorodeoxyglucose F18 , Positron-Emission Tomography/methods , Vulvar Neoplasms/diagnostic imaging , Female , Humans , Image Processing, Computer-AssistedABSTRACT
OBJECTIVE: We reviewed the safety of nuclear diuretic renography with furosemide in patients with sulfonamide allergies. The electronic health record was used to uncover any drug effects reported within 30 days of diuretic renograms performed between January 2009 and December 2015. CONCLUSION: Eighty-three of 1103 (7.5%) diuretic renograms were performed on patients with sulfonamide allergies. Two instances of minor rash occurred. No serious reactions occurred. Furosemide is associated with an extremely low risk of minor reactions in patients with sulfonamide allergies.
Subject(s)
Diuretics/administration & dosage , Diuretics/adverse effects , Drug Hypersensitivity , Furosemide/administration & dosage , Furosemide/adverse effects , Patient Safety , Radioisotope Renography , Sulfonamides/adverse effects , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Retrospective StudiesABSTRACT
RATIONALE AND OBJECTIVES: Coronary artery calcium is a sensitive risk predictor of cardiac events. However, measurement of calcium foci is affected by partial-volume effects, which ultimately have an effect on accuracy and reproducibility of calcium scores. In this study, we describe the accuracy of quantification of calcium foci of known size and density using cork-dog heart phantoms. MATERIALS AND METHODS: Five study phantoms were constructed from cork chests and dog hearts containing 135 calcium hydroxyapatite (CaHA) foci of known volume, mass, and concentration located in the coronary arteries or the myocardium. Hearts were separated into two groups: (1) three hearts containing large, high-density foci and (2) two hearts containing small, low-density foci. The phantoms were scanned using a standard coronary artery calcium (CAC) protocol and the volume and mean intensity of foci were measured. RESULTS: In group 1, the total volume of 87 CaHA foci measured was 4284 and 3779 mm(3) with electron beam computed tomography (EBCT); multidetector computed tomography (MDCT), respectively (P < .001). Both were significantly larger than the true volume (2713.9 mm(3), P < .001). In Group 2, the total volume of 57 CaHA foci measured was 592.6 and 702.9 mm(3) with EBT and MDCT, respectively (P < .001). Both were significantly smaller than the true volume (1733.2 mm(3), P < .001). We found that EBCT values for volume were approximately generally higher than MDCT values, but strongly correlated (r = 0.95, P < .0001). Agatston scores were found to be nearly equivalent between EBCT and MDCT and were similarly strongly correlated (r = 0.97, P < .0001). CONCLUSIONS: Computed tomography images overestimate the volume of large, dense CaHA foci while underestimating the volume of smaller (<6.6 mm(3)), less dense foci. This may have significant implications on CAC scoring and volume measurement. EBCT overestimated calcium more than MDCT, most likely from increased image noise.